• 1. Isopropyllithium diamine adducts: from a non symmetric aggregate to monomeric i-PrLi·(1R,2R)-N,N,N′,N′-tetraethylcyclohexane-1,2-diamine
  Carsten Strohmann,Viktoria H. Gessner,A. Damme i-PrLi·(1R2R)-NNN′N′-tetraethylcyclohexane-12-diamine. Carsten Strohmann Viktoria H. Gessner A. Damme Chem. Commun. 2008 3381
• 2. Isopropyllithium diamine adducts: from a non symmetric aggregate to monomeric i-PrLi·(1R,2R)-N,N,N′,N′-tetraethylcyclohexane-1,2-diamine
  Carsten Strohmann,Viktoria H. Gessner,A. Damme i-PrLi·(1R2R)-NNN′N′-tetraethylcyclohexane-12-diamine. Carsten Strohmann Viktoria H. Gessner A. Damme Chem. Commun. 2008 3381
• 3. Unexpected structural motifs in diamine coordination compounds with allyllithium
  Prisca K. Eckert,Barbara Schnura,Carsten Strohmann Chem. Commun. 2014 50 2532
• 4. Ruthenium complexes of P-stereogenic phosphines with a heterocyclic substituent
  Pau Clavero,Arnald Grabulosa,Mercè Rocamora,Guillermo Muller,Mercè Font-Bardia Dalton Trans. 2016 45 8513
• 5. Three-component 1,2-carboamination of vinyl boronic esters via amidyl radical induced 1,2-migration
  Cai You,Armido Studer Chem. Sci. 2021 12 15765

• Solvents and Organic Chemicals Organic Compounds Hydrocarbon derivatives

Introduction to Lithium, (1-methylethyl)- (9CI) and Its Applications in Modern Research

Lithium, (1-methylethyl)- (9CI), with the CAS number 1888-75-1, is a compound that has garnered significant attention in the field of chemical and pharmaceutical research. This compound, also known as isopropyl lithium, is a lithium alkyl that has found applications in various chemical syntheses and as a reagent in organic transformations. The unique properties of Lithium, (1-methylethyl)- (9CI) make it a valuable tool for researchers exploring new methodologies and materials.

TheCAS number 1888-75-1 provides a unique identifier for this compound, ensuring accurate documentation and communication within the scientific community. This standardized naming convention is crucial for maintaining consistency in research papers, patents, and regulatory filings. The compound's structure, featuring a lithium center bonded to an isopropyl group, contributes to its reactivity and utility in synthetic chemistry.

In recent years, there has been a surge in research focused on the applications of lithium compounds in pharmaceuticals. Lithium, (1-methylethyl)- (9CI) has been explored as a potential intermediate in the synthesis of more complex molecules. Its ability to participate in nucleophilic substitutions and other organic reactions makes it a versatile building block for chemists. Furthermore, the compound's stability under various reaction conditions enhances its appeal as a reagent in both academic and industrial settings.

One of the most intriguing aspects of Lithium, (1-methylethyl)- (9CI) is its role in catalytic processes. Researchers have discovered that it can act as a co-catalyst or activator in certain reactions, improving yield and efficiency. This discovery has opened up new avenues for developing more efficient synthetic routes. For instance, its use in cross-coupling reactions has shown promise in constructing carbon-carbon bonds, which are essential for creating complex organic molecules.

The pharmaceutical industry has also shown interest in Lithium, (1-methylethyl)- (9CI) due to its potential applications in drug development. While it is not currently used as a therapeutic agent itself, its derivatives have been investigated for their pharmacological properties. The compound's ability to interact with biological systems suggests that it could be used to develop new drugs targeting specific pathways or diseases. Ongoing studies are exploring its role in modulating neurological and inflammatory conditions.

Advances in computational chemistry have further enhanced the understanding of Lithium, (1-methylethyl)- (9CI). Molecular modeling techniques allow researchers to predict its behavior in different environments and reactions with high accuracy. This computational insight has been instrumental in designing experiments and optimizing synthetic protocols. By leveraging these tools, scientists can more efficiently explore the compound's potential applications without extensive trial-and-error experimentation.

The environmental impact of using lithium compounds like Lithium, (1-methylethyl)- (9CI) is another area of growing interest. As sustainable chemistry becomes increasingly important, researchers are seeking ways to minimize waste and reduce energy consumption during synthesis. The compound's high reactivity can be both an advantage and a challenge in this context. While it enables rapid transformations, it also requires careful handling to prevent unwanted side reactions. Efforts are underway to develop greener synthetic methods that incorporate this valuable reagent.

In conclusion, Lithium, (1-methylethyl)- (9CI), identified by the CAS number 1888-75-1, is a compound with diverse applications in modern chemical research. Its role as a reagent in organic synthesis and its potential contributions to pharmaceutical development make it a subject of intense study. As research continues to uncover new uses for this compound, its importance in advancing scientific knowledge is likely to grow.

• 3002-94-6(Lithium, cyclopropyl-)
• 2123-72-0(1,4-Dilithiobutane)
• 594-19-4(LITHIUM-2-METHYL-2-PROPANIDE)
• 598-30-1(lithium(1+) ion butan-2-ide)
• 25395-78-2(Lithium, tetrakis[m3-(1,1-dimethylethyl)]tetra-(9CI))
• 10017-08-0(3-Pentenenitrile,2-hydroxy-, (R)- (9CI))
• 2417-93-8(Lithium, propyl-(6CI,7CI,8CI,9CI))
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)